BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Powrie F, Read S, Mottet C, Uhlig H, Maloy K. Control of immune pathology by regulatory T cells. Novartis Found Symp 2003;252:92-8; discussion 98-105, 106-14. [PMID: 14609214] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Engevik MA, Ruan W, Esparza M, Fultz R, Shi Z, Engevik KA, Engevik AC, Ihekweazu FD, Visuthranukul C, Venable S, Schady DA, Versalovic J. Immunomodulation of dendritic cells by Lactobacillus reuteri surface components and metabolites. Physiol Rep 2021;9:e14719. [PMID: 33463911 DOI: 10.14814/phy2.14719] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
2 Sarkar S, Keswani T, Sengupta A, Mitra S, Bhattacharyya A. Differential modulation of glial cell mediated neuroinflammation in Plasmodium berghei ANKA infection by TGF β and IL 6. Cytokine 2017;99:249-59. [DOI: 10.1016/j.cyto.2017.07.026] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
3 Webb CR, Grisham MB. Mouse Models of Chronic Intestinal Inflammation: Characterization and Use in Pharmacological Intervention Studies. Crohn's Disease and Ulcerative Colitis 2017. [DOI: 10.1007/978-3-319-33703-6_15] [Reference Citation Analysis]
4 Zhang J, Romero J, Chan A, Goss J, Stucka S, Cross J, Chamberlain B, Varoglu M, Chandonnet H, Ryan D, Lippa B. Biarylsulfonamide CCR9 inhibitors for inflammatory bowel disease. Bioorganic & Medicinal Chemistry Letters 2015;25:3661-4. [DOI: 10.1016/j.bmcl.2015.06.046] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
5 Sacco R, Tanaka T, Yamamoto T, Bresci G, Saniabadi AR. Adacolumn leucocytapheresis for ulcerative colitis: clinical and endoscopic features of responders and unresponders. Expert Rev Gastroenterol Hepatol 2015;9:327-33. [PMID: 25160857 DOI: 10.1586/17474124.2014.953060] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
6 Huang H, Sun W, Liang Y, Peng Y, Long X, Liu Z, Wen X, Jia M, Tian R, Bai C, Li C. CD4 +CD25 +Treg cells and IgA nephropathy patients with tonsillectomy: a clinical and pathological study. Int Urol Nephrol 2014;46:2361-9. [DOI: 10.1007/s11255-014-0851-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
7 Saniabadi AR, Tanaka T, Ohmori T, Sawada K, Yamamoto T, Hanai H. Treating inflammatory bowel disease by adsorptive leucocytapheresis: A desire to treat without drugs. World J Gastroenterol 2014; 20(29): 9699-9715 [PMID: 25110409 DOI: 10.3748/wjg.v20.i29.9699] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 57] [Article Influence: 6.0] [Reference Citation Analysis]
8 Huang H, Sun W, Liang Y, Long XD, Peng Y, Liu Z, Wen X, Jia M. CD(+)(4)CD(+)(25) Treg cells in thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus patients. Ren Fail 2014;36:1263-7. [PMID: 24990576 DOI: 10.3109/0886022X.2014.934649] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
9 Jones-Hall YL, Grisham MB. Immunopathological characterization of selected mouse models of inflammatory bowel disease: Comparison to human disease. Pathophysiology. 2014;21:267-288. [PMID: 24935242 DOI: 10.1016/j.pathophys.2014.05.002] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 5.4] [Reference Citation Analysis]
10 Shen C, Yan WZ, Zhao CY, Che HH, Liu XY, Liu ZZ, Wang YD, Wang W, Li M, Gao J. Increased CD4+CD25+ regulatory T cells correlate with poor short-term outcomes in hepatitis B virus-related acute-on-chronic liver failure patients. J Microbiol Immunol Infect. 2015;48:137-146. [PMID: 24388581 DOI: 10.1016/j.jmii.2013.11.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
11 Rossi O, van Baarlen P, Wells JM. Host-Recognition of Pathogens and Commensals in the Mammalian Intestine. Curr Top Microbiol Immunol. 2011; Dec 17. [Epub ahead of print]. [PMID: 22179258 DOI: 10.1007/82_2011_191] [Cited by in Crossref: 10] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
12 Huang H, Peng Y, Long XD, Liu Z, Wen X, Jia M, Liang Y, Huang A. Tonsillar CD4+CD25+ regulatory T cells from IgA nephropathy patients have decreased immunosuppressive activity in experimental IgA nephropathy rats. Am J Nephrol 2013;37:472-80. [PMID: 23635548 DOI: 10.1159/000350533] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
13 Koboziev I, Karlsson F, Ostanin DV, Gray L, Davidson M, Zhang S, Grisham MB. Role of LFA-1 in the activation and trafficking of T cells: implications in the induction of chronic colitis. Inflamm Bowel Dis 2012;18:2360-70. [PMID: 22488891 DOI: 10.1002/ibd.22947] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
14 C Falcão S, de Moura TR, Clarêncio J, Brodskyn C, Barral A, de Oliveira CI. The presence of Tregs does not preclude immunity to reinfection with Leishmania braziliensis. Int J Parasitol 2012;42:771-80. [PMID: 22705204 DOI: 10.1016/j.ijpara.2012.05.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
15 Hill D, Eastaff‐leung N, Bresatz‐atkins S, Warner N, Ruitenberg J, Krumbiegel D, Pederson S, Mcinnes N, Brown CY, Sadlon T, Barry SC. Inhibition of activation induced CD154 on CD4 + CD25 cells: a valid surrogate for human Treg suppressor function. Immunol Cell Biol 2012;90:812-21. [DOI: 10.1038/icb.2012.18] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
16 Freitas do Rosario AP, Langhorne J. T cell-derived IL-10 and its impact on the regulation of host responses during malaria. Int J Parasitol 2012;42:549-55. [PMID: 22549022 DOI: 10.1016/j.ijpara.2012.03.010] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 5.3] [Reference Citation Analysis]
17 Tietze JK, Sckisel GD, Hsiao HH, Murphy WJ. Antigen-specific versus antigen-nonspecific immunotherapeutic approaches for human melanoma: the need for integration for optimal efficacy? Int Rev Immunol 2011;30:238-93. [PMID: 22053969 DOI: 10.3109/08830185.2011.598977] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
18 Karlsson F, Koboziev I, Grisham MB. Preclinical Studies Using Mouse Models of Inflammatory Bowel Disease. Crohn's Disease and Ulcerative Colitis 2012. [DOI: 10.1007/978-1-4614-0998-4_16] [Reference Citation Analysis]
19 Païdassi H, Acharya M, Zhang A, Mukhopadhyay S, Kwon M, Chow C, Stuart LM, Savill J, Lacy-Hulbert A. Preferential expression of integrin αvβ8 promotes generation of regulatory T cells by mouse CD103+ dendritic cells. Gastroenterology 2011;141:1813-20. [PMID: 21745448 DOI: 10.1053/j.gastro.2011.06.076] [Cited by in Crossref: 91] [Cited by in F6Publishing: 94] [Article Influence: 7.6] [Reference Citation Analysis]
20 Nagase K, Fukunaga K, Kashiwamura S, Kono T, Kamikozuru K, Yokoyama Y, Hida N, Ohda Y, Takeda N, Yoshida K, Iimuro M, Kikuyama R, Kato K, Miwa H, Matsumoto T. Immunoregulatory Effects of Adsorptive Granulocyte and Monocyte Apheresis in Patients with Drug Refractory Crohn's Disease: Immunoregulatory Effects of GMA in CD. Therapeutic Apheresis and Dialysis 2011;15:367-73. [DOI: 10.1111/j.1744-9987.2011.00970.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
21 Feng X, Li B, Ye H, Long D. Increased frequency of CD4+CD25(high)FoxP3+ regulatory T cells in patients with hepatocellular carcinoma. Arch Immunol Ther Exp (Warsz). 2011;59:309-314. [PMID: 21633918 DOI: 10.1007/s00005-011-0127-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
22 Koboziev I, Karlsson F, Zhang S, Grisham MB. Pharmacological intervention studies using mouse models of the inflammatory bowel diseases: translating preclinical data into new drug therapies. Inflamm Bowel Dis 2011;17:1229-45. [PMID: 21312318 DOI: 10.1002/ibd.21557] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 4.6] [Reference Citation Analysis]
23 Rook GAW, Dalgleish A. Infection, immunoregulation, and cancer: Infection, immunoregulation, and cancer. Immunological Reviews 2011;240:141-59. [DOI: 10.1111/j.1600-065x.2010.00987.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 73] [Article Influence: 5.8] [Reference Citation Analysis]
24 Takebayashi K, Koboziev I, Ostanin DV, Gray L, Karlsson F, Robinson-Jackson SA, Kosloski-Davidson M, Dooley AB, Zhang S, Grisham MB. Role of the gut-associated and secondary lymphoid tissue in the induction of chronic colitis. Inflamm Bowel Dis 2011;17:268-78. [PMID: 20812332 DOI: 10.1002/ibd.21447] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
25 Gridley DS, Luo-owen X, Rizvi A, Makinde AY, Pecaut MJ, Mao XW, Slater JM. Low-dose Photon and Simulated Solar Particle Event Proton Effects on Foxp3 + T Regulatory Cells and other Leukocytes. Technol Cancer Res Treat 2010;9:637-49. [DOI: 10.1177/153303461000900612] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
26 Saniabadi AR, Hanai H. Therapeutic apheresis from the early civilizations to the twenty-first century. Gastroenterol Clin Biol 2010;34:645-8. [PMID: 20971590 DOI: 10.1016/j.gcb.2010.09.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
27 Najib E, Puranik R, Duflou J, Xia Q, Bao S. Age related inflammatory characteristics of coronary artery disease. Int J Cardiol 2012;154:65-70. [PMID: 20888054 DOI: 10.1016/j.ijcard.2010.09.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
28 Goligorsky M, Patschan D, Kuo M, Park H, Hochegger K, Rosenkranz A, Brady H, Mayadas T. Cell Adhesion Molecules in Renal Injury. Comprehensive Toxicology 2010. [DOI: 10.1016/b978-0-08-046884-6.00813-7] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
29 Kotlyar DS, Blonski WC, Lichtenstein GR. Advances in Understanding the Pathogenesis of Inflammatory Bowel Disease. Handbook of Cell Signaling 2010. [DOI: 10.1016/b978-0-12-374145-5.00338-7] [Reference Citation Analysis]
30 Luther C, Adamopoulou E, Stoeckle C, Brucklacher-Waldert V, Rosenkranz D, Stoltze L, Lauer S, Poeschel S, Melms A, Tolosa E. Prednisolone treatment induces tolerogenic dendritic cells and a regulatory milieu in myasthenia gravis patients. J Immunol 2009;183:841-8. [PMID: 19542375 DOI: 10.4049/jimmunol.0802046] [Cited by in Crossref: 69] [Cited by in F6Publishing: 70] [Article Influence: 4.9] [Reference Citation Analysis]
31 Vorobjova T, Uibo O, Heilman K, Rägo T, Honkanen J, Vaarala O, Tillmann V, Ojakivi I, Uibo R. Increased FOXP3 expression in small-bowel mucosa of children with coeliac disease and type I diabetes mellitus. Scand J Gastroenterol 2009;44:422-30. [PMID: 19096978 DOI: 10.1080/00365520802624177] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
32 Rook GAW. Introduction: The changing microbial environment, Darwinian medicine and the hygiene hypothesis. The Hygiene Hypothesis and Darwinian Medicine 2009. [DOI: 10.1007/978-3-7643-8903-1_1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
33 Grisham MB. Do different animal models of IBD serve different purposes? Inflamm Bowel Dis 2008;14 Suppl 2:S132-3. [PMID: 18816751 DOI: 10.1002/ibd.20682] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
34 Rook GA, Lowry CA. The hygiene hypothesis and psychiatric disorders. Trends Immunol 2008;29:150-8. [PMID: 18328783 DOI: 10.1016/j.it.2008.01.002] [Cited by in Crossref: 83] [Cited by in F6Publishing: 74] [Article Influence: 5.5] [Reference Citation Analysis]
35 Piccirillo CA. CD4+Foxp3+Regulatory T Cells in Immune Tolerance. Regulatory T Cells and Clinical Application 2008. [DOI: 10.1007/978-0-387-77909-6_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
36 Neyestani TR. Polyphenols and Immunity. Wild-Type Food in Health Promotion and Disease Prevention 2008. [DOI: 10.1007/978-1-59745-330-1_28] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
37 Saniabadi AR, Hanai H, Fukunaga K, Sawada K, Shima C, Bjarnason I, Lofberg R. Therapeutic leukocytapheresis for inflammatory bowel disease. Transfus Apher Sci. 2007;37:191-200. [PMID: 17974479 DOI: 10.1016/j.transci.2007.08.003] [Cited by in Crossref: 66] [Cited by in F6Publishing: 68] [Article Influence: 4.1] [Reference Citation Analysis]
38 Rook GA. The hygiene hypothesis and the increasing prevalence of chronic inflammatory disorders. Trans R Soc Trop Med Hyg 2007;101:1072-4. [PMID: 17619029 DOI: 10.1016/j.trstmh.2007.05.014] [Cited by in Crossref: 85] [Cited by in F6Publishing: 90] [Article Influence: 5.3] [Reference Citation Analysis]
39 Chidlow JH Jr, Shukla D, Grisham MB, Kevil CG. Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues. Am J Physiol Gastrointest Liver Physiol 2007;293:G5-G18. [PMID: 17463183 DOI: 10.1152/ajpgi.00107.2007] [Cited by in Crossref: 113] [Cited by in F6Publishing: 120] [Article Influence: 7.1] [Reference Citation Analysis]
40 Ostanin DV, Furr KL, Pavlick KP, Gray L, Kevil CG, Shukla D, D'Souza D, Hoffman JM, Grisham MB. T cell-associated CD18 but not CD62L, ICAM-1, or PSGL-1 is required for the induction of chronic colitis. Am J Physiol Gastrointest Liver Physiol 2007;292:G1706-14. [PMID: 17332469 DOI: 10.1152/ajpgi.00573.2006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
41 Rook GA, Hamelmann E, Rosa Brunet L. Mycobacteria and allergies. Immunobiology 2007;212:461-73. [DOI: 10.1016/j.imbio.2007.03.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
42 Huang H, Peng Y, Liu F, Lei H. Is IgA nephropathy induced by abnormalities of CD4+CD25+Treg cells in the tonsils? Medical Hypotheses 2007;69:410-3. [DOI: 10.1016/j.mehy.2006.11.050] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
43 Bopp T, Jonuleit H, Schmitt E. Regulatory T cells--the renaissance of the suppressor T cells. Ann Med 2007;39:322-34. [PMID: 17701475 DOI: 10.1080/07853890701379700] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
44 Barcelos W, Martins-Filho OA, Guimarães TM, Oliveira MH, Spíndola-de-Miranda S, Carvalho BN, Toledo Vde P. Peripheral blood mononuclear cells immunophenotyping in pulmonary tuberculosis patients before and after treatment. Microbiol Immunol 2006;50:597-605. [PMID: 16924144 DOI: 10.1111/j.1348-0421.2006.tb03834.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
45 Xystrakis E, Boswell SE, Hawrylowicz CM. T regulatory cells and the control of allergic disease. Expert Opin Biol Ther 2006;6:121-33. [PMID: 16436038 DOI: 10.1517/14712598.6.2.121] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 3.1] [Reference Citation Analysis]
46 Rook GA, Dheda K, Zumla A. Immune systems in developed and developing countries; implications for the design of vaccines that will work where BCG does not. Tuberculosis (Edinb) 2006;86:152-62. [PMID: 16510309 DOI: 10.1016/j.tube.2006.01.018] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 1.8] [Reference Citation Analysis]
47 Ni Choileain N, MacConmara M, Zang Y, Murphy TJ, Mannick JA, Lederer JA. Enhanced regulatory T cell activity is an element of the host response to injury. J Immunol 2006;176:225-36. [PMID: 16365414 DOI: 10.4049/jimmunol.176.1.225] [Cited by in Crossref: 79] [Cited by in F6Publishing: 85] [Article Influence: 4.6] [Reference Citation Analysis]
48 Granger DN, Grisham MB, Kevil CG. Recruitment of Inflammatory and Immune Cells in the Gut: Physiology and Pathophysiology. Physiology of the Gastrointestinal Tract 2006. [DOI: 10.1016/b978-012088394-3/50049-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
49 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2005; 13(24): 2866-2869 [DOI: 10.11569/wcjd.v13.i24.2866] [Reference Citation Analysis]
50 Walther M, Tongren JE, Andrews L, Korbel D, King E, Fletcher H, Andersen RF, Bejon P, Thompson F, Dunachie SJ, Edele F, de Souza JB, Sinden RE, Gilbert SC, Riley EM, Hill AV. Upregulation of TGF-β, FOXP3, and CD4+CD25+ Regulatory T Cells Correlates with More Rapid Parasite Growth in Human Malaria Infection. Immunity 2005;23:287-96. [DOI: 10.1016/j.immuni.2005.08.006] [Cited by in Crossref: 271] [Cited by in F6Publishing: 264] [Article Influence: 15.1] [Reference Citation Analysis]
51 Wolf D, Hochegger K, Wolf AM, Rumpold HF, Gastl G, Tilg H, Mayer G, Gunsilius E, Rosenkranz AR. CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice. J Am Soc Nephrol 2005;16:1360-70. [PMID: 15788479 DOI: 10.1681/ASN.2004100837] [Cited by in Crossref: 143] [Cited by in F6Publishing: 146] [Article Influence: 7.9] [Reference Citation Analysis]